MissionIR Articles
-
MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Reports on Q3 2023 Financial Results, Business Update
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, is reporting its third-quarter 2023 financial results and key achievements. According to the report, revenue growth increased 44% for the company compared…
-
SenesTech Inc. (NASDAQ: SNES) Webcast at Lytham Fall Investor Conference Highlights Company’s Innovation and Growth with New Solution for Rodent Control
Rodent control innovator SenesTech (NASDAQ: SNES) is delivering a new method of administering its unique, patented contraceptive technology that serves as a form of birth control in both male and female rats, making SenesTech’s solution…
-
MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Now Taking Orders for Evolve(TM) Soft Bait
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, announced that it is now taking orders from commercial customers for Evolve(TM) Soft Bait (“Evolve(TM)”), a solution designed to reduce fertility in…
-
SenesTech Inc. (NASDAQ: SNES) Geometrically Increases its Addressable Market with the Addition of Evolve(TM) Soft Bait to its Portfolio
SenesTech (NASDAQ: SNES), a rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats, just announced the launch of its Evolve(TM) Soft Bait (“Evolve”), a minimum-risk solution in…
-
MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Brings Sustainable Solution for Rising Demand in ‘Rattiest Cities’
A recent Fox Business article discussed pest control company Orkin’s annual ranking of the “Top 50 Rattiest Cities,” where Chicago continues to top the list, followed by Los Angeles, New York City, Washington, D.C., and…
-
MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Featured in Virtual Webcast at Lytham Partners Fall 2023 Investor Conference
SenesTech (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, presented virtually in a webcast presentation as part of of the Lytham Partners Fall 2023…
-
Pest Control Innovator SenesTech Inc. (NASDAQ: SNES) Offers Unique Solution to Tackle the Spread of Rats Amid Growing Health Concerns
Controlling rat populations and the diseases associated with them has been a concern for centuries, underlined in the public consciousness by historical plagues believed to be spread by rats, including the 14th century “Black Death”…
-
SenesTech Inc. (NASDAQ: SNES) Eager to Work with Cities to Address Rat Crises Using Effective Fertility-Restricting Method
Once threatened by the sudden COVID-induced closure of businesses and restaurants, which forced rats to adapt by moving to residential areas in search of food or die – renowned rodentologist Bobby Corrigan estimates that hundreds…
-
SenesTech Inc. (NASDAQ: SNES) to Deploy ContraPest Solutions for Wastewater Facilities in Washington and California
SenesTech (NASDAQ: SNES), the rodent fertility control experts and the inventor of the only EPA-registered contraceptive for male and female rats, recently announced that its ContraPest(R) is being deployed in Washington and California through wastewater…
-
SenesTech Inc. (NASDAQ: SNES) Is ‘One to Watch’
SenesTech (NASDAQ: SNES) is the rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats. The company’s technology provides an innovative and humane method for managing rat populations.…
Search Articles
Latest Articles
- Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergy
- Soligenix Inc. (NASDAQ: SNGX) Secures Key European Milestone for Dusquetide Development
- HeartBeam Inc. (NASDAQ: BEAT) Moves Forward Focused on Advancing Portable, High-Fidelity Cardiac Monitoring
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Announces 1-for-3 Reverse Share Split to Maintain Nasdaq Listing Compliance
- MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Opens Palm Beach Clinic for Depression and PTSD Treatment